Rising Patient Pool Is Expected To Drive The Semaglutide Market Growth
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that is used to treat type 2 diabetes and obesity. It works by stimulating the release of insulin from the pancreas, suppressing glucagon secretion from the pancreas which helps to control blood sugar levels. It also slows down emptying of the stomach and increases feelings of fullness to help in weight loss. Semaglutide is...
0 Comments 0 Shares